![]() |
|
|
Vol. 61, Issue 5, 982-988, May 2002
Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan (Y.N., H.K., Y.S.); and Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo Japan (H.E.)
| |
Abstract |
|---|
|
|
|---|
We reported previously that an efficient efflux system for
benzylpenicillin (PCG) is located on the choroid plexus (CP). In this
study, we investigated the involvement of rat organic anion transporter
1 (rOat1; Slc22a6) and rOat3 (Slc22a8) in
the uptake of PCG and p-aminohippurate (PAH) by the CP.
Western blot analysis indicates the expression of rOat3, but not rOat1,
on the CP, and immunohistochemical staining shows that rOat3 is
localized on the brush border membrane of the choroid epithelial cells.
PCG and PAH were found to be taken up by isolated rat CP, with
Km values of 111 and 354 µM, respectively.
A mutual inhibition study suggests that the same transporter is
responsible for the uptake of PCG and PAH by isolated rat CP. This was
confirmed by examining the effect of organic anions and cimetidine on
their uptake. Estradiol-17
-glucuronide and cimetidine were found to
be selective inhibitors of rOat3. The inhibition constants of the
inhibitors including estradiol-17
-glucuronide and cimetidine were
comparable for the uptake of PAH and PCG by isolated rat CP. In
addition, these values were also comparable with those for rOat3, but
not with those for rOat1. These results suggest that rOat3 is mainly
responsible for the uptake of PCG and PAH by isolated rat CP, and it
functions as one of the detoxification systems on the CP by removing
its substrates from the cerebrospinal fluid.
| |
Introduction |
|---|
|
|
|---|
The
choroid plexus (CP), located in the lateral, third, and fourth
ventricles, is the site of the production of cerebrospinal fluid (CSF),
and it is also responsible for the homeostasis of the environment
surrounding the brain by keeping the composition of the CSF constant
(Segal, 2001
). It is well established that the CP acts as a barrier
between the CSF and the circulating blood (Suzuki et al., 1997
;
Spector, 2000
; Gao and Meier, 2001
; Ghersi-Egea and Strazielle, 2001
;
Haselbach et al., 2001
; Kusuhara and Sugiyama, 2001
); this is achieved
partly by the tight monolayer of the choroid epithelial cells and
partly by the detoxification systems, such as metabolism in the CP, and
efflux transport (Suzuki et al., 1997
; Spector, 2000
; Gao and Meier,
2001
; Ghersi-Egea and Strazielle, 2001
; Haselbach et al., 2001
;
Kusuhara and Sugiyama, 2001
). Organic anions, such as
estradiol-17
-glucuronide (E217
G),
benzylpenicillin (PCG), and cefodizime (
-lactam antibiotics) in the
CSF are actively transported from the CSF into the circulating blood
across the CP (Suzuki et al., 1997
; Spector 2000
; Haselbach et al.,
2001
; Kusuhara and Sugiyama 2001
). We demonstrated previously that the CP is the site of elimination of PCG from the CSF (Suzuki et al., 1997
). A series of uptake studies using isolated rat CP revealed that
an anion exchanger is involved in the uptake of PCG by the CP (Suzuki
et al., 1997
). Mutual inhibition studies provided kinetic evidence to
suggest that this transporter is also responsible for the uptake of a
variety of compounds, such as cefodizime (a
-lactam antibiotic),
dideoxyinosine (a nucleoside analog), fleroxacin (a new quinolone
antibiotic), fluorescein, and phenol red, by the CP (Suzuki et al.,
1997
; Hakvoort et al., 1998
). However, the responsible transporter
remains unidentified (Suzuki et al., 1997
; Nishino et al., 1999
;
Kusuhara and Sugiyama, 2001
).
The present study was carried out to investigate whether rat organic
anion transporter 1 (rOat1; Slc22a6) and/or rOat3
(Slc22a8) is expressed on the CP and is responsible for the
uptake of PCG by the CP, if expressed. rOat1 has been isolated from rat
kidney by expression cloning using Xenopus laevis oocytes
(Sekine et al., 1997
). The transport via rOat1 is driven by an outward
concentration gradient of dicarboxylates, and its substrates include
organic anions such as p-aminohippurate (PAH), a typical
organic anion for the renal organic anion transporter, PCG, and
nucleoside analogs (Inui et al., 2000
; Sekine et al., 2000
; Van Aubel
et al., 2000
; Dresser et al., 2001
). Transcription of mouse Oat1
(mOat1) in the CP was detected between embryonic days 12 and 16 (e12
and e16) of embryo development by in situ hybridization, but it was not
detected in the newborn and adult CP (Pavlova et al., 2000
). In
contrast, Pritchard et al. (1999)
demonstrated that the properties of
2,4-dichlorophenoxyacetate uptake by the CP are similar to those of
rOat1 and suggested that the latter is involved in transport. The
Ki value of PCG for rOat1 is
significantly larger (1.7 mM; Jariyawat et al., 1999
; Hasegawa et al.,
2002
) than the Km value for the uptake
of PCG by isolated rat CP (approximately 80 µM), suggesting that
rOat1 may account for a low-affinity component, if expressed.
We have isolated rOat3, a third member of the organic anion transporter
family, from rat brain using homology screening (Kusuhara et al.,
1999
). Northern blot analysis indicates its expression in the liver,
kidney, brain, and, weakly, in the eye (Kusuhara et al., 1999
). The
transcript of mOat3 was detected in the CP from e14 of embryo
development, but the expression of mOat3 in the adult CP is unclear
(Pavlova et al., 2000
). According to our preliminary experiments, PCG
is a good substrate for rOat3, with a
Km value similar to that for the
uptake of PCG by the CP, and a fragment corresponding to rOat3 was
amplified by the use of reverse transcription-polymerase chain reaction
using cDNA prepared from adult rat CP, prompting us to hypothesize that
rOat3 is responsible for the uptake of PCG by the CP. In this study, we
examined the expression and localization of rOat1 and rOat3 in the CP
and compared kinetic parameters for the uptake of PAH and PCG by
isolated rat CP and by LLC-PK1 cells expressing rOat1 and rOat3.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials. [3H]PAH and [14C]PAH (4.08 Ci/mmol and 50.4 mCi/mmol, respectively) and [3H]H2O were purchased from PerkinElmer Life Sciences (Boston, MA), and [3H]PCG and [14C]PCG (19.0 Ci/mmol and 56.0 mCi/mmol, respectively) were obtained from Amersham Biosciences (Little Chalfont, Buckinghamshire, UK). All cell culture media and reagents were obtained from Invitrogen (Carlsbad, CA), except for fetal bovine serum, which was obtained from Cansera International (Rexdale, Ontario, Canada). All other chemicals and reagents were of analytical grade and were readily available from commercial sources.
Antiserum and Western Blot Analysis.
Antiserum against rOat1
and rOat3 were raised in rabbits against a synthetic peptide consisting
of the 16 carboxyl-terminal amino acids of rOat1 and rOat3,
respectively. Membrane fractions were prepared from LLC-PK1 cells
expressing rOat1 and rOat3 and from kidney, as described previously
(Sugiyama et al., 2001
; Hasegawa et al., 2002
). The membrane fractions
and CP isolated from the lateral ventricles were diluted with loading
buffer (BioLabs, Hertfordshire, UK). These specimens were boiled for 3 min and then loaded onto a 10% SDS-polyacrylamide electrophoresis gel with a 4.4% stacking gel. For Western blotting, the proteins were electrophoretically transferred to a polyvinylidene difluoride membrane
(Amersham) using a blotter (Trans-Blot; Bio-Rad, Hercules, CA) at 15 V
for 1 h. The membrane was blocked with Tris-buffered saline
containing 0.05% Tween 20 (TBS-T) and 5% skimmed milk for 1 h at
room temperature. After washing with TBS-T, the membrane was incubated
with anti-rOat3 serum (dilution, 1:1000). The membrane was then allowed
to bind a horseradish peroxidase-labeled anti-rabbit IgG antibody
(Amersham) diluted to 1:5000 in TBS-T for 1 h at room temperature
followed by washing with TBS-T.
Immunofluorescence Study. Frozen sections from male Sprague-Dawley rats purchased from Japan SLC (Shizuoka, Japan) were prepared after fixing in acetone at 4°C for 10 min. Nonspecific protein binding was blocked by incubation with Nonspecific Staining Blocking Reagent (DAKO, Carpinteria, CA). Sections were incubated with anti-rOat3 antibodies (1:200) for 1 h at room temperature, washed three times with TBS-T, and subsequently incubated with the secondary antibodies labeled with fluorescein isothiocyanate for 30 min at room temperature and mounted in VECTASHIELD Mounting Medium with propidium iodide (Vector Laboratories, Burlingame, CA). The specificity of the antibody reaction was verified by negative controls that were incubated with antiserum that had been blocked with the antigenic peptide.
Uptake Studies in cDNA-Transfected LLC-PK1 Cells.
The cDNA
transfectants (LLC-PK1 cells expressing rOat1 and rOat3) were
established previously, and all the procedures have been described in
detail (Sugiyama et al., 2001
). Cells were seeded on a 12-well dish (BD
Biosciences, Franklin Lakes, NJ) at a density of 1.2 × 105 cells/well and were cultured for 3 days.
Sodium butyrate (5 mM) was added to the culture medium to induce
expression of the transporter 24 h before starting the experiments
(Sugiyama et al., 2001
). Uptake was initiated by adding medium
containing radiolabeled ligands after cells had been washed twice and
preincubated with Krebs-Henseleit buffer at 37°C for 15 min. This
buffer consists of 142 mM NaCl, 23.8 mM
Na2CO3, 4.83 mM KCl, 0.96 mM KH2PO4, 1.20 mM
MgSO4, 12.5 mM HEPES, 5 mM glucose, and 1.53 mM
CaCl2 adjusted to pH 7.4. The uptake was
terminated at a designed time by adding ice-cold Krebs-Henseleit
buffer, and cells were kept overnight in 500 µl of 1 N NaOH for
lysis. The radioactivity associated with the cells and medium was
determined by liquid scintillation counting after adding 2 ml of
scintillation fluid (Hionic-Fluor; Packard Instrument Co., Meriden, CT)
to the vials. The remaining 20-µl portions of cell lysate were used
to determine the protein concentration by the Lowry method, with the
use of bovine serum albumin as a standard.
Uptake of PAH and PCG by Isolated Rat CP.
Male
Sprague-Dawley rats weighing 250 to 300 g were purchased from
Japan SLC. The uptake of [14C]PCG and
[14C]PAH by isolated rat CP was examined by the
use of centrifugal filtration as described in detail previously (Suzuki
et al., 1986
). The CP was isolated from the lateral ventricles and
incubated at 37°C for 1 min in 500 µl of artificial CSF, consisting
of 122 mM NaCl, 25 mM NaHCO3, 10 mM glucose, 3 mM
KCl, 1.4 mM CaCl2, 1.2 mM
MgSO4, 0.4 mM
K2HPO4, and 10 mM HEPES, pH
7.3, equilibrated with 95% O2/5%
CO2. Radiolabeled ligands, with or without
inhibitors, were added to initiate uptake. The tissue-to-medium
concentration ratio of [14C]PCG and
[14C]PAH was calculated with
[3H]H2O as a cell water
space marker to correct for the adherent water space. The
3H and 14C activity in the
specimens was determined in a liquid scintillation spectrophotometer
(LS6000SE; Beckman Coulter, Inc., Fullerton, CA).
Kinetic Analyses.
Kinetic parameters were obtained using the
Michaelis-Menten equation: v = Vmax × S/(Km + S) + Pdif × S, where
v is the uptake rate of the substrate (in picomoles per
minute per milligram of protein or picomoles per minute per milliliter
of tissue), S is the substrate concentration in the medium
(micromolar), Km is the
Michaelis-Menten constant (micromolar), and
Vmax is the maximum uptake rate (in
picomoles per minute per milligram of protein or picomoles per minute
per milliliter of tissue). Pdif
represents the uptake clearance corresponding to the nonsaturable
component (milliliters per minute per milligram of protein or
milliliters per minute per milliliter of tissue). To obtain the kinetic
parameters, the equation was fitted to the uptake velocity using a
MULTI program (Yamaoka et al., 1981
). The input data were
weighted as the reciprocals of the observed values and the Damping
Gauss Newton Method algorithm was used for fitting. Inhibition
constants (Ki) of several compounds were calculated by assuming competitive inhibition. An inhibitory effect was investigated by examining the uptake of PCG by rOat3 at 5 min and that of PAH by rOat1 at 1 min, as well as examining the uptake
of PCG and PAH by CP at 5 min.
| |
Results |
|---|
|
|
|---|
Expression of rOat1 and rOat3 on the CP.
The expression of
rOat1 and rOat3 in their cDNA-transfected cells, CP, and kidney was
examined by Western blot analysis (Fig. 1). Immunoreactive protein was detected
at approximately 63 and 50 kDa in LLC-PK1 cells expressing rOat3 by
rOat3 antiserum and at 63 kDa in the CP, respectively (Fig. 1a, lanes 2 and 3). The molecular mass of rOat3 detected in the kidney was slightly
greater than that in the CP (Fig. 1a, lanes 3 and 4). These bands were abolished when preabsorbed antiserum for rOat3 was used (Fig. 1a, lanes
5-8), suggesting that the positive bands were specific for the antigen
peptide. rOat1 antiserum detected a single band at a molecular mass of
69 kDa in LLC-PK1 cells expressing rOat1 and the kidney (Fig. 1b, lanes
1 and 4). Although a faint band was detected by rOat1-antiserum in the
CP (Fig. 1b, lane 3), this was ascribed to nonspecific binding because
the band was even detected by preabsorbed antiserum (Fig. 1b, lane 7).
|
Localization of rOat3 on rat CP.
The basal surface of the
choroid epithelial cells is apposed to a capillary bed, whereas the
brush border surface, covered with microvilli, faces the CSF. As shown
in Fig. 2, the positive signal of rOat3
is localized on the brush border membrane (BBM) of the choroid
epithelial cells. Preincubating the antiserum of rOat3 with antigen
abolished the signal (data not shown). Positive signals were observed
in the CP when a frozen section of rat brain was incubated with rOat1
antiserum (data not shown). However, it was not abolished by
preabsorption of the antiserum for rOat1 (data not shown), suggesting
that the positive signal observed on the CP is caused by nonspecific
binding.
|
Uptake of PAH and PCG by LLC-PK1 Cells Expressing rOat1 and
rOat3.
The time profiles of the uptake of PAH and PCG by rOat1 and
rOat3 are shown in Fig. 3. The
intracellular accumulation of PAH and PCG by LLC-PK1 cells expressing
rOat3 was significantly greater than that by vector-transfected cells
(Fig. 3, a and b). Because the uptake of PAH and PCG by LLC-PK1 cells
expressing rOat3 increased linearly for up to 5 min of incubation
(Figs. 3a), the uptake of PAH and PCG at 5 min was used for further
studies. The uptake of PAH and PCG by LLC-PK1 cells expressing rOat3
was saturated at higher substrate concentration. Kinetic analysis
showed that the Km and
Vmax values and the uptake clearance
for the nonsaturable component of PCG uptake by rOat3 were 82.6 ± 31.5 µM, 172 ± 67 pmol/min/mg of protein, and 0.758 ± 0.123 µl/min/mg of protein, respectively (Fig.
4a; Table 1). Although
the uptake of PAH by LLC-PK1 cells expressing rOat3 was significantly
greater than that by vector-transfected cells, the saturable component
accounts for 30% of the total uptake by LLC-PK1 cells expressing
rOat3, indicating that the intrinsic transport activity of PAH by rOat3 is quite small compared with that of PCG (approximately 10-fold smaller).
|
|
|
Effect of Organic Anions and Cimetidine on the Uptake of PCG and
PAH by rOat1 and rOat3.
The effect of organic anions, such as
estrone sulfate, E217
G, and probenecid, and an
organic cation, cimetidine, on rOat1-mediated PAH uptake and
rOat3-mediated PCG uptake was examined (Fig. 6). The
Ki values of these compounds were
obtained by assuming competitive inhibition, and they are summarized in
Table 1. Probenecid and estrone sulfate were the most potent inhibitors
for rOat3, whereas cimetidine and E217
G were
moderate inhibitors (Fig. 6; Table 1). Because cimetidine and
E217
G do not inhibit the uptake by rOat1 at
all (Fig. 6, Table 1) (Sugiyama et al., 2001
), the involvement of rOat1
can be discriminated by examining their inhibitory effect on the uptake
of PAH and PCG by isolated rat CP.
Uptake of PCG and PAH by Isolated Rat CP.
The time profiles of
the uptake of PAH and PCG by isolated rat CP are shown in Fig.
5a. The uptake of PAH and PCG by isolated rat CP increased linearly for up to 5 min of incubation. Their uptake
at 5 min was used to examine the concentration-dependence and the
effect of various inhibitors. Kinetic analysis revealed that the uptake
of PCG and PAH consists of one saturable and one nonsaturable component
(Fig. 5). The Km and
Vmax values for the uptake of PCG and
PAH by isolated rat CP were determined to be 111 ± 19 µM and
224 ± 32 pmol/min/µl of tissue, and 354 ± 84 µM and
154 ± 34 pmol/min/µl of tissue, respectively. The uptake
clearance corresponding to the nonsaturable component was 0.246 ± 0.025 µl/min/µl of tissue and 0.0927 ± 0.0104 µl/min/µl
of tissue, respectively. The uptake of PCG by isolated rat CP under
linear conditions
(Vmax/Km) was 5-fold greater than that of PAH.
|
Effect of Organic Anions and Cimetidine on the Uptake of PCG and
PAH by Isolated Rat CP.
The effect of the inhibitors, described
previously, on the uptake of PAH and PCG by isolated rat CP was
examined. Probenecid is the most potent inhibitor of the uptake of PAH
and PCG by isolated rat CP, whereas estrone sulfate, cimetidine, and
E217
G are moderate inhibitors (Fig.
6). The inhibition constants of these
inhibitors are summarized in Table 1. The
Ki values were comparable for the
uptake of PAH and PCG by isolated rat CP (Table 1, Fig.
7). In addition, the
Ki and
Km values were also comparable with
those for rOat3 but not with those for rOat1 (Table 1, Fig. 7).
|
|
| |
Discussion |
|---|
|
|
|---|
In this study, we demonstrated the expression and localization of
rOat3 on isolated rat CP and the involvement of rOat3 in the uptake of
PCG and PAH by isolated rat CP. Because Pritchard et al. (1999)
proposed the functional involvement of rOat1 in the uptake of
2,4-dichlorophenoxyacetic acid by the CP, we also examined the
expression of rOat1 on the CP.
The expression of rOat1 and rOat3 on the CP was studied with the use of Western blot analysis. A band was detected in the CP by rOat3 antiserum (Fig. 1a), and its molecular mass was slightly smaller than that in the kidney. This may be caused by a difference in the degree of glycosylation. Immunohistochemical staining indicates that rOat3 is located on the BBM of the CP (Fig. 2). Because the BBM of the CP faces the CSF, the localization of rOat3 suggests its involvement in removing exogenous and endogenous compounds from the CSF. On the other hand, rOat1 antiserum failed to detect any band in the CP (Fig. 1b, lane3), whereas it detected a single band in LLC-PK1 cells expressing rOat1 and in the kidney (Fig. 1b, lanes 1 and 4). These results indicate that the expression of rOat1 on the CP is either very low or zero.
The localization of rOat3 on the CP differs from that in the kidney,
where it is localized on the basolateral membrane (BLM) of the proximal
tubules (Cha et al., 2001
; Hasegawa et al., 2002
). The same
tissue-specific localization was also reported in the case of
Na+/K+ ATPase and reduced
folate carrier, which exhibit the same pattern as rOat3, i.e., the BLM
of the kidney and the BBM of the CP (Marrs et al., 1993
; Wang et al.,
2001
). In addition, rOat1-green fluorescent fusion protein,
transfected exogenously into the CP, was localized on the BBM of the CP
(Pritchard et al., 1999
), although it is localized on the BLM of
Fundulus heteroclitus proximal tubules when it is exogenously transfected (Sweet et al., 1999
). The presence of a tissue-specific membrane-sorting mechanism has been considered, although the molecular mechanism remains to be clarified.
According to the transport study using cDNA transfected cells, PAH and
PCG are good probes to detect the transport activity by rOat1 and
rOat3, respectively. Significant uptake of PCG and PAH was observed in
isolated rat CP (Fig. 5). Both the absolute value of the uptake and the
Km value for the uptake of PCG by isolated rat CP were comparable with previously reported values (Suzuki
et al., 1987
). The uptake of PAH was 5-fold smaller than that of
PCG (Fig. 5). As summarized in Table 1, the results from the mutual
inhibition study suggest that, kinetically, PAH and PCG share the same
uptake system on the CP. This was also supported by comparing the
Ki values of inhibitors, including a
selective inhibitor of rOat3, of the uptake of PAH and PCG, which were
found to be similar (Table 1, Fig. 7). In addition, these parameters (Km and
Ki values) were also similar to those
for rOat3, but not for rOat1 (Table 1, Fig. 7). In conjunction with the
results of the Western blot analysis and immunohistochemical staining, we conclude that rOat3 is mainly responsible for the uptake of PCG and
PAH by the CP.
Rat organic anion transporting polypeptide 1 (rOatp1;
Slc21a1) has been demonstrated to be localized on the BBM of
the CP (Angeletti et al., 1997
; Nishino et al., 1999
), it has been
isolated from rat liver by expression cloning using X. laevis oocytes, and it has been shown to be a multispecific
transporter for amphipathic organic anions such as
E217
G and bile acids (Bossuyt et al., 1996
;
Muller and Jansen 1997
). There is an overlap in substrates between
rOatp1 and rOat3 [e.g., E217
G, estrone
sulfate, ochratoxin A, and pravastatin (Eckhardt et al., 1999
; Kusuhara
et al., 1999
; Sugiyama et al., 2001
; Hasegawa et al., 2002
)],
suggesting that some common ligands may be removed from the CSF by both
rOatp1 and rOat3. The contribution of rOatp1 and rOat3 to the total
uptake of organic anions by the CP should be evaluated in further
studies to reveal the role of these organic anion transporters in the elimination of organic anions from the CSF. Taking their substrate specificity into consideration, we hypothesize that rOatp1 is responsible mainly for the uptake of amphipathic organic anions by the
CP, whereas rOat3 is mainly responsible for the uptake of less
hydrophobic organic anions. Consequently, the uptake system for organic
anions located on the BBM of the CP may cover a wide range of organic
anions and may remove their substrates efficiently from the CSF.
To excrete xenobiotics from the CSF into the circulating blood, efflux
transporters are required on the BLM of the CP (Suzuki et al., 1997
;
Wijnholds et al., 2000
;Gao and Meier, 2001
). However, transport across
the BLM has not yet been fully characterized. rMrp1 and rOatp2 have
been demonstrated to be expressed on the BLM of choroid epithelial
cells (Gao et al., 2000
; Wijnholds et al., 2000
). Because rOatp2 is a
bidirectional transporter (Li et al., 2000
), it is possible that the
uptake and excretion of organic anions on the BLM is mediated by
rOatp2, although its function on the BLM of the CP has not yet been
demonstrated (Gao et al., 1999
). The role of Mrp1 on the CP as an
excretion mechanism has been demonstrated by comparing the CSF
concentration of etoposide between Mdr1a/Mdr1b double knockout mice and
Mdr1a/Mdr1b/Mrp1 triple knockout mice (Wijnholds et al., 2000
). The CSF
concentration of etoposide significantly increased in Mdr1a/Mdr1b/Mrp1
triple knockout mice compared with Mdr1a/Mdr1b double knockout mice. The contribution of these transporters to the elimination of organic anions needs to be examined in future studies.
In conclusion, our studies have shown that rOat3 is mainly responsible for the uptake of PCG and PAH by the CP. It is one of the uptake mechanisms for the removal of organic anions from the CSF together with rOatp1.
| |
Acknowledgments |
|---|
We thank Hitoshi Sato and Dr. Kazuo Suzuki (Pharmaceutical Research Institute, Kyowa Hakko Kogyo, Shizuoka, Japan) and Dr. Naomi Motoji (Institute of Whole Body Metabolism, Chiba, Japan) for processing the immunohistochemical staining.
| |
Footnotes |
|---|
Received September 24, 2001; Accepted January 25, 2002
This work was supported by Grants-in-Aid from the Ministry of Health, Labor, and Welfare of Japan.
Address correspondence to: Yuichi Sugiyama, Ph.D., Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. E-mail: sugiyama{at}mol.f.u-tokyo.ac.jp
| |
Abbreviations |
|---|
CP, choroid plexus;
CSF, cerebrospinal fluid;
E217
G, estradiol-17
-glucuronide;
PAH, p-aminohippurate;
Oat, organic anion transporter;
Oatp, organic anion transporter polypeptide;
m, mouse;
r, rat;
PCG, benzylpenicillin;
TBS-T, Tris-buffered saline/Tween 20;
BBM, brush border membrane;
BLM, basolateral membrane.
| |
References |
|---|
|
|
|---|
-lactam antibiotics with the cloned rat renal organic anion transporter 1.
J Pharmacol Exp Ther
290:
672-677
-estradiol-D-17
-glucuronide from the brain across the blood-brain barrier.
J Pharmacol Exp Ther
298:
316-322This article has been cited by other articles:
![]() |
M. Hong, F. Zhou, K. Lee, and G. You The Putative Transmembrane Segment 7 of Human Organic Anion Transporter hOAT1 Dictates Transporter Substrate Binding and Stability J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1209 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bahn, M. Ljubojevic, H. Lorenz, C. Schultz, E. Ghebremedhin, B. Ugele, I. Sabolic, G. Burckhardt, and Y. Hagos Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1075 - C1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lowes, D. Sykes, C. M. Breen, L. J. Ragone, and D. S. Miller Multiple Components of 2,4-Dichlorophenoxyacetic Acid Uptake by Rat Choroid Plexus J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 136 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tahara, H. Kusuhara, H. Endou, H. Koepsell, T. Imaoka, E. Fuse, and Y. Sugiyama A Species Difference in the Transport Activities of H2 Receptor Antagonists by Rat and Human Renal Organic Anion and Cation Transporters J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morita, H. Kusuhara, Y. Nozaki, H. Endou, and Y. Sugiyama FUNCTIONAL INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 2 (SLC22A7) IN THE HEPATIC UPTAKE OF THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG KETOPROFEN Drug Metab. Dispos., August 1, 2005; 33(8): 1151 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuroda, H. Kusuhara, H. Endou, and Y. Sugiyama Rapid Elimination of Cefaclor from the Cerebrospinal Fluid Is Mediated by a Benzylpenicillin-Sensitive Mechanism Distinct from Organic Anion Transporter 3 J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 855 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagata, H. Kusuhara, S. Hirono, H. Endou, and Y. Sugiyama CARRIER-MEDIATED UPTAKE OF H2-RECEPTOR ANTAGONISTS BY THE RAT CHOROID PLEXUS: INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 3 Drug Metab. Dispos., September 1, 2004; 32(9): 1040 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Breen, D. B. Sykes, C. Baehr, G. Fricker, and D. S. Miller Fluorescein-methotrexate transport in rat choroid plexus analyzed using confocal microscopy Am J Physiol Renal Physiol, September 1, 2004; 287(3): F562 - F569. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imaoka, H. Kusuhara, S. Adachi-Akahane, M. Hasegawa, N. Morita, H. Endou, and Y. Sugiyama The Renal-Specific Transporter Mediates Facilitative Transport of Organic Anions at the Brush Border Membrane of Mouse Renal Tubules J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2012 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohtsuki, T. Kikkawa, S. Mori, S. Hori, H. Takanaga, M. Otagiri, and T. Terasaki Mouse Reduced in Osteosclerosis Transporter Functions as an Organic Anion Transporter 3 and Is Localized at Abluminal Membrane of Blood-Brain Barrier J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1273 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kobayashi, N. Ohshiro, A. Tsuchiya, N. Kohyama, M. Ohbayashi, and T. Yamamoto RENAL TRANSPORT OF ORGANIC COMPOUNDS MEDIATED BY MOUSE ORGANIC ANION TRANSPORTER 3 (MOAT3): FURTHER SUBSTRATE SPECIFICITY OF MOAT3 Drug Metab. Dispos., May 1, 2004; 32(5): 479 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sykes, D. H. Sweet, S. Lowes, S. K. Nigam, J. B. Pritchard, and D. S. Miller Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice Am J Physiol Renal Physiol, May 1, 2004; 286(5): F972 - F978. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nozaki, H. Kusuhara, H. Endou, and Y. Sugiyama Quantitative Evaluation of the Drug-Drug Interactions between Methotrexate and Nonsteroidal Anti-Inflammatory Drugs in the Renal Uptake Process Based on the Contribution of Organic Anion Transporters and Reduced Folate Carrier J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 226 - 234. [Abstract] [Full Text] |
||||
![]() |
S. A. Eraly, K. T. Bush, R. V. Sampogna, V. Bhatnagar, and S. K. Nigam The Molecular Pharmacology of Organic Anion Transporters: from DNA to FDA? Mol. Pharmacol., March 1, 2004; 65(3): 479 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Ocheltree, H. Shen, Y. Hu, J. Xiang, R. F. Keep, and D. E. Smith Mechanisms of Cefadroxil Uptake in the Choroid Plexus: Studies in Wild-Type and PEPT2 Knockout Mice J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 462 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, M. Tu, R. S. Kelly, C. Chen, and B. J. Smith DEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITY Drug Metab. Dispos., January 1, 2004; 32(1): 132 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Choudhuri, N. J. Cherrington, N. Li, and C. D. Klaassen CONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATS Drug Metab. Dispos., November 1, 2003; 31(11): 1337 - 1345. [Abstract] |